ECO has received a positive opinion from the EMA for the use of the water-soluble formulation of Aivlosin to treat an d control mycoplasmosis in pigs. This is the usual precursor to full Marketing Authorisation in a couple of months, with European launch therefore expected in H2 ahead of the peak Autumn/Winter respiratory disease season. Mycoplasmosis is a key economic disease in pigs and this additional market expansion for Aivlosin represents a valuable additional growth driver for the grou
22 May 2020
European positive opinion on additional indication for Aivlosin in Pigs
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
European positive opinion on additional indication for Aivlosin in Pigs
ECO Animal Health Group plc (EAH:LON) | 94.0 0 0.0% | Mkt Cap: 63.7m
- Published:
22 May 2020 -
Author:
Chris Glasper -
Pages:
3
ECO has received a positive opinion from the EMA for the use of the water-soluble formulation of Aivlosin to treat an d control mycoplasmosis in pigs. This is the usual precursor to full Marketing Authorisation in a couple of months, with European launch therefore expected in H2 ahead of the peak Autumn/Winter respiratory disease season. Mycoplasmosis is a key economic disease in pigs and this additional market expansion for Aivlosin represents a valuable additional growth driver for the grou